MENU
+Compare
FLMNY
Stock ticker: OTC
AS OF
Aug 5 closing price
Price
$12.86
Change
+$0.34 (+2.72%)
Capitalization
5.43B

FLMNY stock forecast, quote, news & analysis

Fielmann Group AG is involved in purchase and sale of goods, in physical stores as well as wholesale and online, particularly in optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems as well as personal protective eqipments... Show more

FLMNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for FLMNY with price predictions
Aug 15, 2025

FLMNY's RSI Indicator ascends from oversold territory

The RSI Indicator for FLMNY moved out of oversold territory on August 05, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 10 similar instances when the indicator left oversold territory. In of the 10 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 13, 2025. You may want to consider a long position or call options on FLMNY as a result. In of 25 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

FLMNY moved above its 50-day moving average on August 05, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for FLMNY turned negative on July 22, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 22 similar instances when the indicator turned negative. In of the 22 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for FLMNY crossed bearishly below the 50-day moving average on August 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for FLMNY entered a downward trend on August 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.128) is normal, around the industry mean (10.935). P/E Ratio (28.299) is within average values for comparable stocks, (62.110). FLMNY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.886). Dividend Yield (0.021) settles around the average of (0.016) among similar stocks. P/S Ratio (1.976) is also within normal values, averaging (40.726).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FLMNY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FLMNY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

A.I.Advisor
published Dividends

FLMNY paid dividends on July 30, 2025

Fielmann Group AG FLMNY Stock Dividends
А dividend of $0.27 per share was paid with a record date of July 30, 2025, and an ex-dividend date of July 14, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 11.04B. The market cap for tickers in the group ranges from 246 to 172.16B. ISRG holds the highest valuation in this group at 172.16B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 4%. TRUMF experienced the highest price growth at 21%, while CUPR experienced the biggest fall at -86%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 5%. For the same stocks of the Industry, the average monthly volume growth was 35% and the average quarterly volume growth was 56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 65
Price Growth Rating: 60
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
FLMNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Weidestrasse 118a
Phone
+49 40270760
Employees
22028
Web
https://www.fielmann-group.com